EMC6
gene geneOn this page
Also known as MGC2963RAB5IFL
Summary
EMC6 (ER membrane protein complex subunit 6, HGNC:28430) is a protein-coding gene on chromosome 17p13.2, encoding ER membrane protein complex subunit 6 (Q9BV81). Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. It is a selective cancer dependency (DepMap: 16.7% of cell lines).
Contributes to membrane insertase activity. Involved in autophagosome assembly; protein insertion into ER membrane by stop-transfer membrane-anchor sequence; and tail-anchored membrane protein insertion into ER membrane. Located in endoplasmic reticulum membrane and omegasome membrane. Part of EMC complex.
Source: NCBI Gene 83460 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 14 total
- Cancer dependency (DepMap): dependent in 16.7% of screened cell lines
- MANE Select transcript:
NM_031298
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28430 |
| Approved symbol | EMC6 |
| Name | ER membrane protein complex subunit 6 |
| Location | 17p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2963, RAB5IFL |
| Ensembl gene | ENSG00000127774 |
| Ensembl biotype | protein_coding |
| OMIM | 620261 |
| Entrez | 83460 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000248378, ENST00000397133, ENST00000890763, ENST00000890764
RefSeq mRNA: 2 — MANE Select: NM_031298
NM_001014764, NM_031298
CCDS: CCDS11033
Canonical transcript exons
ENST00000248378 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001308926 | 3668812 | 3668899 |
| ENSE00002752197 | 3669098 | 3669665 |
Expression profiles
Bgee: expression breadth ubiquitous, 269 present calls, max score 97.22.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 78.9518 / max 375.5162, expressed in 1822 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 158879 | 78.9518 | 1822 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 97.22 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.21 | gold quality |
| muscle of leg | UBERON:0001383 | 96.61 | gold quality |
| muscle organ | UBERON:0001630 | 96.22 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.84 | gold quality |
| apex of heart | UBERON:0002098 | 95.60 | gold quality |
| vastus lateralis | UBERON:0001379 | 95.43 | silver quality |
| quadriceps femoris | UBERON:0001377 | 95.39 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.29 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.20 | gold quality |
| diaphragm | UBERON:0001103 | 95.17 | silver quality |
| biceps brachii | UBERON:0001507 | 95.01 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 94.79 | gold quality |
| right testis | UBERON:0004534 | 94.73 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.64 | gold quality |
| deltoid | UBERON:0001476 | 94.57 | silver quality |
| triceps brachii | UBERON:0001509 | 94.56 | gold quality |
| gluteal muscle | UBERON:0002000 | 94.53 | gold quality |
| left testis | UBERON:0004533 | 94.52 | gold quality |
| heart right ventricle | UBERON:0002080 | 94.42 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.37 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.33 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.24 | gold quality |
| adult organism | UBERON:0007023 | 93.99 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.90 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.81 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.78 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.61 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.54 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting EMC6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-5100 | 99.11 | 67.52 | 1098 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-29B-1-5P | 98.86 | 68.35 | 1364 |
| HSA-MIR-4511 | 98.32 | 67.97 | 1500 |
| HSA-MIR-3155A | 98.16 | 66.09 | 965 |
| HSA-MIR-3155B | 98.16 | 66.09 | 965 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-4438 | 97.96 | 63.70 | 947 |
| HSA-MIR-503-5P | 97.87 | 66.83 | 575 |
| HSA-MIR-1255B-2-3P | 97.80 | 67.04 | 880 |
| HSA-MIR-4521 | 97.73 | 67.64 | 684 |
| HSA-MIR-4694-5P | 94.62 | 65.39 | 532 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 16.7% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 6)
- Endoplasmic membrane protein complex subunit 6 (EMC6) interacted with both RAB5A and BECN1/Beclin 1 and colocalized with the omegasome marker ZFYVE1/DFCP1. (PMID:23182941)
- This is the first study to show that EMC6 induces cell death in gastric cancer cells. The molecular mechanism of how EMC6 functions as a tumor suppressor needs to be further explored. (PMID:28648145)
- The expression level of EMC-6 is significantly elevated in cervical cancer, without significant correlation with Beclin1 and Rab5a. (PMID:28742203)
- Adenovirus-mediated ectopic overexpression of EMC6 (Ad5-EMC6) decreases the activity of ERK1/2, down-regulates the levels of BCL-2 and increases the ratio of BAX/BCL-2. Ad5-EMC6 mediates anti-tumor activity through the mitochondrial apoptosis pathway. Ad5-EMC6 enhances the sensitivity of gastric cancer cells to the etoposide. (PMID:30982575)
- EMC6 regulates acinar apoptosis via APAF1 in acute and chronic pancreatitis. (PMID:33177505)
- Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression. (PMID:38445807)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | emc6 | ENSDARG00000035282 |
| mus_musculus | Emc6 | ENSMUSG00000047260 |
| rattus_norvegicus | Emc6 | ENSRNOG00000019352 |
| drosophila_melanogaster | EMC6 | FBGN0039259 |
| caenorhabditis_elegans | WBGENE00017999 |
Protein
Protein identifiers
ER membrane protein complex subunit 6 — Q9BV81 (reviewed: Q9BV81)
Alternative names: Transmembrane protein 93
All UniProt accessions (1): Q9BV81
UniProt curated annotations — full annotation on UniProt →
Function. Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes.
Subunit / interactions. Component of the ER membrane protein complex (EMC).
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the EMC6 family.
RefSeq proteins (2): NP_001014764, NP_112588* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008504 | Emc6 | Family |
| IPR029008 | EMC6-like | Family |
Pfam: PF07019
UniProt features (19 total): helix 6, topological domain 4, transmembrane region 3, mutagenesis site 2, initiator methionine 1, chain 1, strand 1, modified residue 1
Structure
Experimental structures (PDB)
10 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8J0O | ELECTRON MICROSCOPY | 3.32 |
| 7ADO | ELECTRON MICROSCOPY | 3.39 |
| 6WW7 | ELECTRON MICROSCOPY | 3.4 |
| 8EOI | ELECTRON MICROSCOPY | 3.4 |
| 8J0N | ELECTRON MICROSCOPY | 3.47 |
| 7ADP | ELECTRON MICROSCOPY | 3.6 |
| 8S9S | ELECTRON MICROSCOPY | 3.6 |
| 9ZZ6 | ELECTRON MICROSCOPY | 4.16 |
| 6Z3W | ELECTRON MICROSCOPY | 6.4 |
| 9C7V | ELECTRON MICROSCOPY | 6.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BV81-F1 | 82.32 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 27 | no effect on emc assembly but decreased membrane insertion of hydrophobic transmembrane helices-containing proteins by t |
| 31 | no effect on emc assembly but decreased membrane insertion of hydrophobic transmembrane helices-containing proteins by t |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 138 (showing top):
TSENG_IRS1_TARGETS_UP, GOBP_VACUOLE_ORGANIZATION, PAL_PRMT5_TARGETS_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GGGTGGRR_PAX4_03, YY1_Q6, GOBP_MACROAUTOPHAGY, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_ORGANELLE_ASSEMBLY, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_MEMBRANE_ORGANIZATION, GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION, GOBP_LOCALIZATION_WITHIN_MEMBRANE
GO Biological Process (3): autophagosome assembly (GO:0000045), protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050), tail-anchored membrane protein insertion into ER membrane (GO:0071816)
GO Molecular Function (2): protein binding (GO:0005515), membrane insertase activity (GO:0032977)
GO Cellular Component (5): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), EMC complex (GO:0072546), omegasome membrane (GO:1903349), endoplasmic reticulum (GO:0005783)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein insertion into ER membrane | 2 |
| Atg12 activating enzyme activity | 1 |
| protein-phosphatidylethanolamide deconjugating activity | 1 |
| Atg12 conjugating enzyme activity | 1 |
| Atg12 ligase activity | 1 |
| organelle assembly | 1 |
| Atg1/ULK1 kinase complex assembly | 1 |
| autophagosome organization | 1 |
| binding | 1 |
| establishment of protein localization to membrane | 1 |
| protein carrier activity | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| endoplasmic reticulum membrane | 1 |
| membrane protein complex | 1 |
| endoplasmic reticulum protein-containing complex | 1 |
| bounding membrane of organelle | 1 |
| omegasome | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1174 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EMC6 | EMC1 | Q8N766 | 961 |
| EMC6 | EMC4 | Q5J8M3 | 934 |
| EMC6 | EMC2 | Q15006 | 932 |
| EMC6 | EMC3 | Q9P0I2 | 904 |
| EMC6 | MMGT1 | Q8N4V1 | 898 |
| EMC6 | BECN1 | Q14457 | 807 |
| EMC6 | EMC7 | Q9NPA0 | 806 |
| EMC6 | EMC9 | Q9Y3B6 | 792 |
| EMC6 | RAB5A | P20339 | 771 |
| EMC6 | EMC8 | O43402 | 735 |
| EMC6 | EMC10 | Q5UCC4 | 716 |
| EMC6 | GET1 | O00258 | 623 |
| EMC6 | OXA1L | Q15070 | 621 |
| EMC6 | GET3 | O43681 | 606 |
| EMC6 | PIK3C3 | Q8NEB9 | 535 |
IntAct
92 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EMC2 | EMC8 | psi-mi:“MI:0914”(association) | 0.940 |
| EMC8 | EMC2 | psi-mi:“MI:0914”(association) | 0.940 |
| MMGT1 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.810 |
| EMC6 | MMGT1 | psi-mi:“MI:0915”(physical association) | 0.810 |
| EMC2 | EMC10 | psi-mi:“MI:0914”(association) | 0.800 |
| EMC7 | EMC8 | psi-mi:“MI:0914”(association) | 0.790 |
| MMGT1 | EMC8 | psi-mi:“MI:0914”(association) | 0.730 |
| EMC3 | EMC8 | psi-mi:“MI:0914”(association) | 0.730 |
| EMC10 | EMC8 | psi-mi:“MI:0915”(physical association) | 0.620 |
| TMEM237 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMC6 | SLC39A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMC6 | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMC6 | ERGIC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MUC1 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PDZK1IP1 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP6 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP9 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC10A6 | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM209A | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MMD | EMC6 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (100): EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-RNA), EMC6 (Proximity Label-MS), EMC6 (Proximity Label-MS), EMC6 (Proximity Label-MS), EMC6 (Two-hybrid), EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-MS), EMC6 (Affinity Capture-RNA), EMC6 (Affinity Capture-MS), EMC6 (Negative Genetic)
ESM2 similar proteins: A1CKG4, A1D708, A2XSY1, A4K2N5, A4K2W1, A4R2N5, A6RRF7, A7EMV1, B0XXU1, O43934, O80594, O81214, O95214, O95427, P56982, P56983, P56984, P57758, Q0CNZ5, Q0JDK9, Q1RMQ3, Q32PD8, Q3ZBX1, Q3ZCG8, Q4WXT2, Q56P28, Q5BJW3, Q5PQQ4, Q5RCQ5, Q5RDE9, Q5RFE0, Q5ZLL0, Q62302, Q68EU8, Q6GLC5, Q6P0F0, Q6PDU4, Q6UWH6, Q78S06, Q7ZUA6
Diamond homologs: Q1ZXH4, Q3ZCG8, Q68EU8, Q6GLC5, Q6P0F0, Q9BV81, Q9CQW0
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| EMC6 | “form complex” | “Endoplasmic reticulum membrane complex- EMC9 variant” | binding |
| EMC6 | “form complex” | “Endoplasmic reticulum membrane complex, EMC8 variant” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 50 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| tail-anchored membrane protein insertion into ER membrane | 7 | 152.4× | 2e-12 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
164 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:3668984:G:GT | donor_gain | 1.0000 |
| 17:3669001:G:GT | donor_gain | 1.0000 |
| 17:3669019:G:GT | donor_gain | 1.0000 |
| 17:3668870:C:G | donor_gain | 0.9900 |
| 17:3669096:A:AG | acceptor_gain | 0.9900 |
| 17:3669097:G:GG | acceptor_gain | 0.9900 |
| 17:3669097:GCTCC:G | acceptor_gain | 0.9900 |
| 17:3669002:A:T | donor_gain | 0.9700 |
| 17:3669093:CGCA:C | acceptor_loss | 0.9700 |
| 17:3669094:GCA:G | acceptor_loss | 0.9700 |
| 17:3669096:AGCT:A | acceptor_loss | 0.9700 |
| 17:3669097:GCT:G | acceptor_gain | 0.9600 |
| 17:3669097:GCTC:G | acceptor_gain | 0.9600 |
| 17:3668869:GC:G | donor_gain | 0.9500 |
| 17:3668870:C:CG | donor_gain | 0.9500 |
| 17:3668895:TCCAG:T | donor_loss | 0.9500 |
| 17:3668896:CCAG:C | donor_loss | 0.9500 |
| 17:3668897:CAGG:C | donor_loss | 0.9500 |
| 17:3668898:AG:A | donor_loss | 0.9500 |
| 17:3668899:GG:G | donor_loss | 0.9500 |
| 17:3668900:GTAA:G | donor_loss | 0.9500 |
| 17:3668901:T:A | donor_loss | 0.9500 |
| 17:3669097:GC:G | acceptor_gain | 0.9500 |
| 17:3669007:TGCC:T | donor_gain | 0.9300 |
| 17:3669008:GCCA:G | donor_gain | 0.9300 |
| 17:3669008:GCCAG:G | donor_loss | 0.9300 |
| 17:3669010:CAGGT:C | donor_loss | 0.9300 |
| 17:3669014:T:A | donor_loss | 0.9300 |
| 17:3669019:G:T | donor_gain | 0.9300 |
| 17:3669009:CCAG:C | donor_gain | 0.9200 |
AlphaMissense
681 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:3669259:G:A | G38E | 0.999 |
| 17:3669258:G:T | G38W | 0.998 |
| 17:3669268:C:A | A41D | 0.998 |
| 17:3669270:G:C | G42R | 0.998 |
| 17:3669271:G:A | G42D | 0.998 |
| 17:3669235:G:C | R30P | 0.997 |
| 17:3669258:G:A | G38R | 0.997 |
| 17:3669258:G:C | G38R | 0.997 |
| 17:3669444:T:A | W100R | 0.997 |
| 17:3669444:T:C | W100R | 0.997 |
| 17:3669250:C:A | A35E | 0.996 |
| 17:3669259:G:T | G38V | 0.996 |
| 17:3669267:G:C | A41P | 0.996 |
| 17:3669270:G:T | G42C | 0.996 |
| 17:3669271:G:T | G42V | 0.996 |
| 17:3669297:G:C | G51R | 0.996 |
| 17:3669298:G:A | G51D | 0.996 |
| 17:3669459:G:C | G105R | 0.996 |
| 17:3669436:T:A | V97D | 0.994 |
| 17:3669262:C:A | A39D | 0.993 |
| 17:3669439:T:A | L98Q | 0.993 |
| 17:3669265:C:A | T40K | 0.992 |
| 17:3669283:T:C | L46P | 0.992 |
| 17:3669298:G:T | G51V | 0.992 |
| 17:3669246:T:C | S34P | 0.991 |
| 17:3669261:G:C | A39P | 0.991 |
| 17:3669439:T:C | L98P | 0.991 |
| 17:3669231:T:C | C29R | 0.990 |
| 17:3669280:G:T | G45V | 0.990 |
| 17:3669297:G:T | G51C | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000985695 (17:3669891 G>A), RS1002998018 (17:3667316 C>A), RS1004511970 (17:3669629 C>T), RS1005127053 (17:3669976 G>A), RS1005429563 (17:3668836 C>A,T), RS1005811241 (17:3669029 G>A,C,T), RS1006401292 (17:3667950 G>A), RS1006842701 (17:3667654 T>G), RS1009211895 (17:3668297 G>A), RS1009262881 (17:3668072 C>T), RS1010302024 (17:3668041 C>T), RS1011670925 (17:3667075 G>A), RS1012854546 (17:3669560 G>A,T), RS1013031124 (17:3670117 A>T), RS1013067275 (17:3669974 C>T)
Disease associations
OMIM: gene MIM:620261 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases methylation, increases abundance | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases methylation, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vitamin E | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1R4 | Abcam HeLa EMC6 KO | Cancer cell line | Female |
| CVCL_SL93 | HAP1 EMC6 (-) 1 | Cancer cell line | Male |
| CVCL_SL94 | HAP1 EMC6 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.